Cargando…

Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study

BACKGROUND: Shifting from cytology to human papillomavirus (HPV)-based cervical cancer screening will initially increase colposcopy referrals. The anticipated impact on health systems has been raised as a concern for implementation. It is unclear if the higher rate of colposcopy referrals is sustain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gottschlich, Anna, Gondara, Lovedeep, Smith, Laurie W., Anderson, Jennifer Joy, Cook, Darrel, Krajden, Mel, Lee, Marette, Martin, Ruth Elwood, Melnikow, Joy, Peacock, Stuart, Proctor, Lily, Stuart, Gavin, Franco, Eduardo L., van Niekerk, Dirk, Ogilvie, Gina S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542010/ https://www.ncbi.nlm.nih.gov/pubmed/37786399 http://dx.doi.org/10.1016/j.lana.2023.100598

Ejemplares similares

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Women’s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results
por: Smith, Laurie W, et al.
Publicado: (2021)

Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results
por: Lesack, Anne, et al.
Publicado: (2022)

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial
por: Coldman, Andrew J, et al.
Publicado: (2016)

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial
por: Cromwell, Ian, et al.
Publicado: (2021)

Age-Specific Trends of Invasive Cervical Cancer Incidence in British Columbia, Canada, 1971–2017
por: Raveinthiranathan, Nivedha, et al.
Publicado: (2023)

Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada
por: McClymont, Elisabeth, et al.
Publicado: (2021)

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
por: Cook, Darrel A., et al.
Publicado: (2018)

Sociodemographic characteristics of women with invasive cervical cancer in British Columbia, 2004–2013: a descriptive study
por: Simkin, Jonathan, et al.
Publicado: (2021)

Towards targeted screening for acute HIV infections in British Columbia
por: Steinberg, Malcolm, et al.
Publicado: (2011)

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)
por: Ogilvie, Gina S, et al.
Publicado: (2010)

Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples
por: Racey, C Sarai, et al.
Publicado: (2022)

Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program
por: Racey, C Sarai, et al.
Publicado: (2020)

Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia
por: Gilbert, Mark, et al.
Publicado: (2013)

Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women—implications for vaccination
por: Moore, Richard A., et al.
Publicado: (2009)

HCV co-infection in HIV positive population in British Columbia, Canada
por: Buxton, Jane A, et al.
Publicado: (2010)

British Columbia’s Experience after Implementation of the Treponema pallidum Reverse Algorithm and PCR Detection, 2015 to 2020
por: Morshed, Muhammad, et al.
Publicado: (2022)

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
por: Romanowski, Kamila, et al.
Publicado: (2017)

Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
por: Smith, Laurie W, et al.
Publicado: (2014)

P232 MOLECULAR PHYLOGENETICS OF HEPATITIS C VIRUS (HCV) AS A TOOL TO UNDERSTAND THE HCV EPIDEMIC IN BRITISH COLUMBIA (BC), CANADA
por: Olmstead, A., et al.
Publicado: (2014)

Cancer Patients’ Experiences with Telehealth before and during the COVID-19 Pandemic in British Columbia
por: Izadi-Najafabadi, Sara, et al.
Publicado: (2022)

A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia
por: Butt, Zahid Ahmad, et al.
Publicado: (2017)

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
por: Binka, Mawuena, et al.
Publicado: (2018)

Mortality among British Columbians testing for hepatitis C antibody
por: Yu, Amanda, et al.
Publicado: (2013)

STI service delivery in British Columbia, Canada; providers' views of their services to youth
por: Masaro, Cindy L, et al.
Publicado: (2012)

Feasibility and Acceptability of a Mobile Technology Intervention to Support Postabortion Care in British Columbia: Phase I
por: Gill, Roopan, et al.
Publicado: (2019)

Human Illness from Avian Influenza H7N3, British Columbia
por: Tweed, S. Aleina, et al.
Publicado: (2004)

Characterizing intentions to receive the COVID-19 vaccine among the general population in British Columbia based on their future intentions towards the seasonal influenza vaccine
por: Sharma, Bhawna, et al.
Publicado: (2022)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
por: Cook, Darrel A., et al.
Publicado: (2015)

Highlight: British Columbia
Publicado: (2005)

The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada
por: Janjua, Naveed, et al.
Publicado: (2022)

SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia
por: Sekirov, Inna, et al.
Publicado: (2021)

Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
por: Wilton, James, et al.
Publicado: (2020)

Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study
por: Pearce, Margo E., et al.
Publicado: (2021)

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
por: Tanunliong, Guadalein, et al.
Publicado: (2022)

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants
por: Janjua, Naveed Zafar, et al.
Publicado: (2016)

Estimating the Cost of Cancer Care in British Columbia and Ontario: A Canadian Inter-Provincial Comparison
por: De Oliveira, Claire, et al.
Publicado: (2017)

Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019
por: Pearce, Margo E., et al.
Publicado: (2020)

Hospital for the Insane in British Columbia
Publicado: (1904)

Cannot write session to /tmp/vufind_sessions/sess_f8t073vikevolp3kb2c17gepri